有没有易受伤害的斑块?

¹Cardiothoracic and Vascular Department, University Vita-Salute San Raffaele, Milan, Italy.

|April 30, 2003

No abstract available in PubMed .

相关概念视频

通过共同作者、期刊和引用图与本文相关的文章。

Atherosclerosis·2025

Frontiers in cardiovascular medicine·2022

International journal of cardiology·2021

International journal of cardiology·2021

International journal of cardiology·2021

Diabetes care·2021

Same journal

Circulation·2026

Same journal

Circulation·2026

Same journal

Circulation·2026

Same journal

Circulation·2026

Same journal

Circulation·2026

Same journal

Circulation·2026

相关实验视频

有没有易受伤害的斑块?

相关概念视频

相关实验视频

有没有易受伤害的斑块?

相关概念视频

相关实验视频

有没有易受伤害的斑块?

相关概念视频

相关文章

Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques.

Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans.

Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance.

Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study.

Family history in first degree relatives of patients with premature cardiovascular disease.

Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851.

Eugene Braunwald, MD, 1929-2026.

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

相关实验视频

有没有易受伤害的斑块?

相关概念视频

相关文章

Leukocyte-shed soluble CD31 unmasks coronary disease in low-risk outliers and provides source-specific inflammatory signatures of vulnerable plaques.

Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans.

Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance.

Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study.

Family history in first degree relatives of patients with premature cardiovascular disease.

Erratum. Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care 2020;43:843-851.

Eugene Braunwald, MD, 1929-2026.

AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.

Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.